Search research articles
Contact Us
Filters
Showing results (31-40 of 116) with videos related to
Page
of 12
Sort By:
Acta Neurochirurgica
|
August 3, 2014
Are patients open to elective re-sampling of their glioblastoma? A new way of assessing treatment innovations
Taskia Mir, Peter Dirks, Warren P Mason, et al.
Journal of Neuro-Oncology
|
August 6, 2022
Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy
Seth A Climans, Warren P Mason, Eva Grunfeld, et al.
Expert Opinion on Investigational Drugs
|
August 5, 2020
Proteasome inhibition for the treatment of glioblastoma
Patrick Roth, Warren P Mason, Paul G Richardson, et al.
Neuro-Oncology Practice
|
August 7, 2019
Assessing behavioral syndromes in patients with brain tumors using the frontal systems behavior scale (FrSBe)
Sergio Cabrera, Kim Edelstein, Warren P Mason, et al.
Future Oncology (London, England)
|
May 27, 2025
Advances in IDH-mutant glioma management: IDH inhibitors, clinical implications of INDIGO trial, and future perspectives
Christianne V Mojica, Katrina Mari E Gutierrez, Warren P Mason
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 21, 2017
Bevacizumab in Recurrent High-Grade Gliomas: A Canadian Retrospective Study
Mary Jane Lim Fat, Catherine Maurice, Manjula Maganti, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
January 4, 2014
Concomitant viral and bacterial encephalitis after temozolomide for glioblastoma
Jenny P Tsai, Nicolae Petrescu, Warren P Mason, et al.
Neuro-Oncology
|
March 21, 2022
Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy
Seth A Climans, Eva Grunfeld, Warren P Mason, et al.
BMJ Case Reports
|
October 30, 2020
Prolonged response to vismodegib in a patient with systemic medulloblastoma metastases
Seth A Climans, David R Macdonald, Duncan Ek Sutherland, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
March 31, 2022
Trametinib for Painful Glomus Tumors in a Patient with Neurofibromatosis Type 1
Seth A Climans, Ronald C Ramos, Dimitri J Anastakis, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 116) with videos related to
Sort By:
Page
of 12
Acta Neurochirurgica
|
August 3, 2014
Are patients open to elective re-sampling of their glioblastoma? A new way of assessing treatment innovations
Taskia Mir, Peter Dirks, Warren P Mason, et al.
Journal of Neuro-Oncology
|
August 6, 2022
Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy
Seth A Climans, Warren P Mason, Eva Grunfeld, et al.
Expert Opinion on Investigational Drugs
|
August 5, 2020
Proteasome inhibition for the treatment of glioblastoma
Patrick Roth, Warren P Mason, Paul G Richardson, et al.
Neuro-Oncology Practice
|
August 7, 2019
Assessing behavioral syndromes in patients with brain tumors using the frontal systems behavior scale (FrSBe)
Sergio Cabrera, Kim Edelstein, Warren P Mason, et al.
Future Oncology (London, England)
|
May 27, 2025
Advances in IDH-mutant glioma management: IDH inhibitors, clinical implications of INDIGO trial, and future perspectives
Christianne V Mojica, Katrina Mari E Gutierrez, Warren P Mason
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 21, 2017
Bevacizumab in Recurrent High-Grade Gliomas: A Canadian Retrospective Study
Mary Jane Lim Fat, Catherine Maurice, Manjula Maganti, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
January 4, 2014
Concomitant viral and bacterial encephalitis after temozolomide for glioblastoma
Jenny P Tsai, Nicolae Petrescu, Warren P Mason, et al.
Neuro-Oncology
|
March 21, 2022
Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy
Seth A Climans, Eva Grunfeld, Warren P Mason, et al.
BMJ Case Reports
|
October 30, 2020
Prolonged response to vismodegib in a patient with systemic medulloblastoma metastases
Seth A Climans, David R Macdonald, Duncan Ek Sutherland, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
March 31, 2022
Trametinib for Painful Glomus Tumors in a Patient with Neurofibromatosis Type 1
Seth A Climans, Ronald C Ramos, Dimitri J Anastakis, et al.
Page
of 12